Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Eur J Cancer. 2020 Jul 20;136:176–185. doi: 10.1016/j.ejca.2020.06.015

Figure 1.

Figure 1.

Flowchart of trial screening, eligibility, and inclusion. Disease-related outcomes (DROs) includes outcomes related to disease control and/or survival; non-DRO endpoints include those assessing disease- or treatment-related toxicities, supportive measures, and similar. Abbreviations: RCT, randomized controlled trials; DRO, disease-related outcome; PEP, primary endpoint; PFS, progression-free survival; OS, overall survival.